By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
MedsparkMedsparkMedspark
  • Home
  • News & Alerts
    News & AlertsShow More
    Ohio State and Microsoft build a hospital that senses itself
    By
    msadmin
    November 11, 2026
    Charta raises $55M to settle claims before doctors bill
    By
    msadmin
    November 11, 2026
    Oura spends $625M to put doctors behind its ring
    By
    msadmin
    November 11, 2026
    Google puts an agent layer under every hospital workflow
    By
    msadmin
    November 11, 2026
    XtalPi hands Pierre Fabre a molecule factory for stubborn cancer targets
    By
    msadmin
    November 10, 2026
  • Spotlight
    SpotlightShow More
    Robinhood Ventures Fund II brings retail capital to healthcare AI
    By
    msadmin
    August 13, 2026
    Adialante brings accessible MRI-based cancer screening
    By
    msadmin
    August 11, 2026
    CellType models biology so AI can discover drugs
    By
    msadmin
    August 11, 2026
    Healthcare AI startups in Robinhood Ventures Fund II
    By
    msadmin
    August 11, 2026
    OpenAI launches GPT-Rosalind for life sciences research
    By
    msadmin
    July 17, 2026
  • Articles
    ArticlesShow More
    Singapore clinics let an AI watch for referrals nobody ever sent
    By
    msadmin
    November 1, 2026
    An AI team of agents grades immunotherapy side effects
    By
    msadmin
    October 30, 2026
    Brain implant decoders fail when patients or hardware change, review warns
    By
    msadmin
    October 25, 2026
    Proteomics model picks breast cancer drugs from biopsies
    By
    msadmin
    September 10, 2026
    CRISP model reads frozen sections to steer cancer surgery
    By
    msadmin
    September 10, 2026
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Font ResizerAa
MedsparkMedspark
Font ResizerAa
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
  • Shop
  • Newsletter
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Follow US
News & Alerts

Medicare’s AI pre-approval test cut targeted care by a fifth

The first study of Medicare's WISeR prior authorization pilot finds epidural steroid injections fell 15% and other targeted services nearly 20% in six states, leaving researchers unable to say whether the skipped care was wasteful or necessary.

MedSpark Staff
By
msadmin
MedSpark Staff
Bymsadmin
Medical, Healthcare, & Biotech/Pharma AI News
Follow:
Published: November 1, 2026
Share
2 Min Read
SHARE

Traditional Medicare spent decades running with almost no prior authorization. In January that changed. A six-year federal pilot called WISeR now requires clinicians in Arizona, New Jersey, Ohio, Oklahoma, Texas and Washington to get sign-off before selected services are covered, and the contractors doing the reviewing are mostly technology firms encouraged to use AI.

Contents
What the numbers showWhat nobody can answer yet

The first independent look at what happened landed in JAMA this week from researchers at the University of Minnesota and Brown University. Their conclusion is blunt: the requirements had an immediate effect, and nobody yet knows whether the care that disappeared was waste or necessary treatment.

What the numbers show

The team pulled monthly service use from Epic Cosmos, an EHR dataset covering more than 300 million patients, and compared the six pilot states against the rest of the country. The window ran 24 months before launch through the first six months after.

Epidural steroid injections, the highest-volume service in the model, fell about 15%. The remaining targeted services fell nearly 20%. Services slated for the pilot but never activated did not decline, which the authors treat as evidence that prior authorization, not an unrelated trend, moved the numbers.

The effect also faded. Injection reductions narrowed from roughly 21% in the opening quarter to about 9% in the next, while other services slipped from 21% to 18%.

What nobody can answer yet

“The key question we can’t yet answer is whether the care not received was wasteful or necessary,” said Hannah Neprash, the study’s lead author. Co-author Michael Barnett warned that added administrative work may not justify a small change in who ultimately gets treated.

The design tracked utilization, not costs, denials or patient outcomes, and covers six months of a six-year pilot. CMS is weighing whether to extend or broaden the model.

TAGGED:AI GovernanceCMShealth economicshealth policyJAMAMedicareprior authorization
SOURCES:MorningstarUniversity of Minnesota School of Public HealthMedical Daily
Share This Article
Facebook Copy Link Print
MedSpark Staff
Bymsadmin
Follow:
Medical, Healthcare, & Biotech/Pharma AI News

You Might Also Like

News & Alerts

Lyric acquires Concert to expand AI precision medicine payments

By
msadmin
July 17, 2026
News & Alerts

AI lung CT analysis catches taladegib effect in a 12-week IPF trial

By
msadmin
September 9, 2026
News & Alerts

Drylab raises $3M to let AI agents run experiments unattended

By
msadmin
October 14, 2026
News & Alerts

Basalt Health cuts the fax pile holding up post-acute admissions

By
msadmin
September 25, 2026

AI news, analysis, and insights for healthcare, biotech, and pharma.

Facebook Twitter Youtube Linkedin
Quick Links
  • News & Alerts
  • Articles
  • Spotlight
  • Events
About Medspark
  • Mission
  • Services
  • Contact

© Copyright 2026 MedSpark. All rights reserved.

Privacy Policy | Legal